Literature DB >> 19339987

Age- and gender-specific modulation of serum osteopontin and interferon-alpha by osteopontin genotype in systemic lupus erythematosus.

S N Kariuki1, J G Moore, K A Kirou, M K Crow, T O Utset, T B Niewold.   

Abstract

Osteopontin (OPN) is a multifunctional cytokine involved in long bone remodeling and immune system signaling. Additionally, OPN is critical for interferon-alpha (IFN-alpha) production in murine plasmacytoid dendritic cells. We have previously shown that IFN-alpha is a heritable risk factor for systemic lupus erythematosus (SLE). Genetic variants of OPN have been associated with SLE susceptibility, and one study suggests that this association is particular to men. In this study, the 3' UTR SLE-risk variant of OPN (rs9138C) was associated with higher serum OPN and IFN-alpha in men (P=0.0062 and P=0.0087, respectively). In women, the association between rs9138 C and higher serum OPN and IFN-alpha was restricted to younger subjects, and risk allele carriers showed a strong age-related genetic effect of rs9138 genotype on both serum OPN and IFN-alpha (P<0.0001). In African-American subjects, the 5' region single nucleotide polymorphisms, rs11730582 and rs28357094, were associated with anti-RNP antibodies (odds ratio (OR)=2.9, P=0.0038 and OR=3.9, P=0.021, respectively). Thus, we demonstrate two distinct genetic influences of OPN on serum protein traits in SLE patients, which correspond to previously reported SLE-risk variants. This study provides a biologic relevance for OPN variants at the protein level, and suggests an influence of this gene on the IFN-alpha pathway in SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339987      PMCID: PMC2762275          DOI: 10.1038/gene.2009.15

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  28 in total

1.  Statistics in epidemiology: the case-control study.

Authors:  N E Breslow
Journal:  J Am Stat Assoc       Date:  1996-03       Impact factor: 5.033

Review 2.  Osteopontin expression and function: role in bone remodeling.

Authors:  D T Denhardt; M Noda
Journal:  J Cell Biochem Suppl       Date:  1998

3.  Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha.

Authors:  J M Vanacker; C Delmarre; X Guo; V Laudet
Journal:  Cell Growth Differ       Date:  1998-12

4.  Possible induction of systemic lupus erythematosus by interferon-alpha treatment in a patient with a malignant carcinoid tumour.

Authors:  L E Rönnblom; G V Alm; K E Oberg
Journal:  J Intern Med       Date:  1990-03       Impact factor: 8.989

5.  An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus.

Authors:  A C Forton; M A Petri; D Goldman; K E Sullivan
Journal:  Hum Mutat       Date:  2002-04       Impact factor: 4.878

6.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

7.  Immune interferon in the circulation of patients with autoimmune disease.

Authors:  J J Hooks; H M Moutsopoulos; S A Geis; N I Stahl; J L Decker; A L Notkins
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

8.  Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease.

Authors:  M A Lampe; R Patarca; M V Iregui; H Cantor
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

9.  Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus.

Authors:  S D'Alfonso; N Barizzone; M Giordano; A Chiocchetti; C Magnani; L Castelli; M Indelicato; F Giacopelli; M Marchini; R Scorza; M G Danieli; M Cappelli; S Migliaresi; B Bigliardo; M G Sabbadini; E Baldissera; M Galeazzi; G D Sebastiani; G Minisola; R Ravazzolo; U Dianzani; P Momigliano-Richiardi
Journal:  Arthritis Rheum       Date:  2005-02

Review 10.  Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C.

Authors:  Timothy B Niewold; William I Swedler
Journal:  Clin Rheumatol       Date:  2004-11-24       Impact factor: 3.650

View more
  57 in total

1.  Genetic variation at the IRF7/PHRF1 locus is associated with autoantibody profile and serum interferon-alpha activity in lupus patients.

Authors:  Rafah Salloum; Beverly S Franek; Silvia N Kariuki; Lesley Rhee; Rachel A Mikolaitis; Meenakshi Jolly; Tammy O Utset; Timothy B Niewold
Journal:  Arthritis Rheum       Date:  2010-02

2.  Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus.

Authors:  Corinna E Weckerle; Beverly S Franek; Jennifer A Kelly; Marissa Kumabe; Rachel A Mikolaitis; Stephanie L Green; Tammy O Utset; Meenakshi Jolly; Judith A James; John B Harley; Timothy B Niewold
Journal:  Arthritis Rheum       Date:  2011-04

Review 3.  Genetic regulation of serum cytokines in systemic lupus erythematosus.

Authors:  Silvia N Kariuki; Timothy B Niewold
Journal:  Transl Res       Date:  2009-09-25       Impact factor: 7.012

Review 4.  Recent insights into the genetic basis of systemic lupus erythematosus.

Authors:  K L Moser; J A Kelly; C J Lessard; J B Harley
Journal:  Genes Immun       Date:  2009-05-14       Impact factor: 2.676

5.  Interferon-alpha: a therapeutic target in systemic lupus erythematosus.

Authors:  Mary K Crow
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

6.  Secreted phosphoprotein 1 is a determinant of lung function development in mice.

Authors:  Koustav Ganguly; Timothy M Martin; Vincent J Concel; Swapna Upadhyay; Kiflai Bein; Kelly A Brant; Leema George; Ankita Mitra; Tania A Thimraj; James P Fabisiak; Louis J Vuga; Cheryl Fattman; Naftali Kaminski; Holger Schulz; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

Review 7.  Genetic associations in type I interferon related pathways with autoimmunity.

Authors:  Angélica M Delgado-Vega; Marta E Alarcón-Riquelme; Sergey V Kozyrev
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

8.  Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus.

Authors:  Silvia N Kariuki; Beverly S Franek; Akaash A Kumar; Jasmine Arrington; Rachel A Mikolaitis; Tammy O Utset; Meenakshi Jolly; Mary K Crow; Andrew D Skol; Timothy B Niewold
Journal:  Arthritis Res Ther       Date:  2010-07-26       Impact factor: 5.156

9.  Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients.

Authors:  Silvia N Kariuki; Beverly S Franek; Rachel A Mikolaitis; Tammy O Utset; Meenakshi Jolly; Andrew D Skol; Timothy B Niewold
Journal:  J Biomed Biotechnol       Date:  2010-07-04

10.  The role of osteopontin in inflammatory processes.

Authors:  Susan Amanda Lund; Cecilia M Giachelli; Marta Scatena
Journal:  J Cell Commun Signal       Date:  2009-10-02       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.